The review by Egloff et al. provides a comprehensive and updated overview of candidate predictive markers in response to EGFR-targeted therapies in HNSCC including Src family kinases and describes recent clinical trials combining Src- and EGFR-targeted therapeutics. The gene discussed is SRC; the disease is head and neck squamous cell carcinoma.